106,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
53 °P sammeln
  • Gebundenes Buch

The authors have produced the first "on the ground" study (not just clinical or chemical) of MDMA (3, 4-methylenedioxymethamphetamine), or "ecstasy" as it is frequently designated. A psychoactive substance related to both the amphetamines and mescaline, MDMA has become popular in recent years as one of the new "designer" drugs. First used in therapeutic treatment, its recreational or street use has increased in recent years. The authors track the efforts (with psychiatrists and researchers in opposition) of the DEA to ban the drug.

Produktbeschreibung
The authors have produced the first "on the ground" study (not just clinical or chemical) of MDMA (3, 4-methylenedioxymethamphetamine), or "ecstasy" as it is frequently designated. A psychoactive substance related to both the amphetamines and mescaline, MDMA has become popular in recent years as one of the new "designer" drugs. First used in therapeutic treatment, its recreational or street use has increased in recent years. The authors track the efforts (with psychiatrists and researchers in opposition) of the DEA to ban the drug.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Jerome Beck is Co-Principal Investigator at the Institute for Scientific Analysis in Berkeley, California. Marsha Rosenbaum is the Director of the Center for Drug Studies and Principal Investigator at the Institute for Scientific Analysis in San Francisco, California. She is the author of Women on Heroin, and Just Say What: An Alternative View on Solving America's Drug Problem.